Here are analysts' favorite Nasdaq 100 stocks for the second half

CNBC Pro screens Nasdaq 100 constituents for stocks with strong fundamentals and cheaper-than-index valuation (forward P/E below ~27) alongside analyst upside (at least 35%). Nvidia leads the list with 83.3% buy endorsements and is cited as the biggest AI beneficiary, while Intuit shows ~74% implied upside (~70% buy ratings) and Strategy (market cap $35.3B) is the smallest with ~200% upside at just 8.2x projected earnings. The article frames the back half as more rate- and geopolitics-sensitive, but highlights valuation support via analyst-backed upside across key names.

Analysis

The market is still paying up for AI duration, so the more interesting opportunity is not the obvious leader but the adjacent compounders with cleaner cash-flow visibility. INTU is the highest-quality way to express a lower-multiple rotation inside QQQ: recurring revenue, pricing power, and less dependence on a continued capex binge from hyperscalers. If rates stay sticky, high-multiple growth names with less durable monetization paths are the ones most likely to see de-rating; TGT-like discretionary cash-flow profiles would also be vulnerable, but that’s more a macro beta expression than a stock-specific edge.

MSTR is a different animal: it trades less on earnings than on liquidity, crypto risk appetite, and the cost of leverage. That makes it a powerful tactical long only if the Fed turns easier or Bitcoin resumes trending, but it is also the cleanest short if policy expectations re-tighten or BTC stalls. NVDA remains the core AI beneficiary, but after a huge rerating the bar is now execution, not narrative; any sign of hyperscaler spend normalization or gross-margin pressure would likely compress the multiple before the fundamentals actually roll over.

The consensus may be missing that “cheap versus QQQ” is not the same as “cheap versus intrinsic value” when the whole index is crowded into a few leadership trades. A narrow leadership tape can persist for months, but it becomes fragile when breadth fades and investors start demanding actual earnings conversion rather than TAM stories. Falsifiers: NVDA upside if next quarter’s supply/capex commentary re-accelerates; INTU underperforms if SMB formation and retention weaken; MSTR breaks if BTC loses trend support and funding conditions tighten. The regime that hurts the screen is not a hard landing — it is a slow-growth, higher-for-longer backdrop that compresses the most duration-sensitive names first.

Key Decisions for Investors

• Initiate a 1-3 month pair trade: long INTU / short QQQ or an equal-notional basket of high-duration AI beta (NVDA, MSTR). Thesis: quality compounder vs crowded multiple; target 8-12% relative outperformance if rates stay firm and breadth rotates.
• Avoid chasing NVDA outright into strength; prefer a pullback entry or a call spread structure for 3-6 months. Risk/reward improves only if hyperscaler capex commentary re-accelerates; otherwise upside is capped by elevated expectations.
• Tactically short MSTR on any BTC failure to hold trend support or if macro rate-cut odds are repriced lower. This is a high-beta liquidity short, not a fundamentals short; cover quickly if BTC resumes momentum.
• If already long QQQ, hedge with a modest INTU overweight rather than a broad index short. This preserves AI exposure while reducing multiple-compression risk if the market rotates away from the most crowded names.